Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/ADMA Biologics shares plunge 24% after withdrawing financial guidance amid fraud allegations.
ADMA
$8.62
-$0.25 -2.87%

ADMA Biologics shares plunge 24% after withdrawing financial guidance amid fraud allegations.

Market News
06 May 2026
GlobeNewsWire
View Source
Bearish
pluang ai news

ADMA Biologics' stock dropped over 24% following the company's withdrawal of its long-term financial guidance due to changing market conditions. This move came after a report accused ADMA of inflating growth through questionable practices related to its product Asceniv. Legal firm Block & Leviton is investigating potential securities violations and encourages affected investors to contact them for possible recovery of losses. Investors who purchased ADMA shares and suffered losses may be eligible for legal action as the investigation continues.

More News (ADMA)

Deadline nears for investors to join class action lawsuits against BTGO, VIA, Z, and ADMA for alleged securities fraud.

Deadline nears for investors to join class action lawsuits against BTGO, VIA, Z, and ADMA for alleged securities fraud.

Law Offices of Howard G. Smith reminds investors of approaching deadlines to file lead plaintiff motions in class action lawsuits against BitGo Holdings, Via Transportation, Zillow Group, and ADMA Biologics. These lawsuits allege the companies made f...

Market News
Bearish
2 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App